Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Cash from Investing Activities (2017 - 2023)

vTv Therapeutics' Cash from Investing Activities history spans 6 years, with the latest figure at $4.4 million for Q4 2023.

  • For Q4 2023, Cash from Investing Activities changed N/A year-over-year to $4.4 million; the TTM value through Dec 2023 reached $4.4 million, changed N/A, while the annual FY2023 figure was $4.4 million, 21071.43% up from the prior year.
  • Cash from Investing Activities for Q4 2023 was $4.4 million at vTv Therapeutics, up from -$68000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $4.4 million in Q4 2023 and bottomed at -$68000.0 in Q4 2019.